Stockholm Bullets - Viscaria Soars on Buy Recommendation

Viscaria's stock surged 12.2% after Handelsbanken's buy recommendation with a target price of 27 kronor. Addvise rose 6% following a raised offer by Amplex. Vitrolife gained 4.5% on a buy recommendation from Dagens industri. Skanska increased 1.1% after announcing major deals. EQT, Minesto, and Arise saw minor changes, while Intrum recorded a significant write-down. Coor appointed a new CFO, Astra Zeneca faced a study setback, and Alvotech began European sales of a biosimilar.